Tryptophan immunoadsorption for multiple sclerosis and neuromyelitis optica relapses during pregnancy and breastfeeding
Recruiting
- Conditions
- G35G36Multiple sclerosisOther acute disseminated demyelination
- Registration Number
- DRKS00011770
- Lead Sponsor
- Apherese Forschungsinstitut
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 15
Inclusion Criteria
Relapse of multiple sclerosis or neuromyelitis optica during pregnancy and breastfeeding. Use of tryptophan immunoadsorption as escalation therapy.
Exclusion Criteria
Patient doesn´t agree to be treated. Treating physician doesn´t want to participate in the documentation.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of tryptophan immunoadsorption for MS and NMO relapse in pregnant and breatfeeding patients by comparing clinical-neurological symptoms before and immediately after the immunodasorption series.<br>
- Secondary Outcome Measures
Name Time Method Tolerability and safety of tryptophan immunoadsorption.